Table 2.
Treatment Time | C1 | C2 | E1 | E2 |
---|---|---|---|---|
RQ | ||||
Week 4 | 0.748 ± 0.022 | 0.738 ± 0.022 | 0.738 ± 0.022 | 0.733 ± 0.020 |
Week 8 | 0.764 ± 0.020 | 0.758 ± 0.015 | 0.753 ± 0.012 | 0.761 ± 0.017 |
Week 10 | 0.771 ± 0.012 b | 0.810 ± 0.015 a | 0.789 ± 0.012 ab | 0.776 ± 0.020 b |
EE (kcal/day/kg0.75) | ||||
Week 4 | 130.4 ± 3.6 b | 141.3 ± 3.7 a | 143.3 ± 4.0 a | 143.8 ± 3.8 a |
Week 8 | 152.9 ± 4.7 a | 139.5 ± 3.5 b | 152.1 ± 4.0 a | 143.9 ± 3.5 b |
Week 10 | 210.8 ± 8.6 a | 176.7 ± 4.1 b | 177.1 ± 5.2 b | 166.5 ± 5.2 b |
Values are mean ± SD, n = 6 mice per group. Mean values within a row with unlike superscript letters are significantly different (p < 0.05) analyzed by one-way ANOVA, followed by Tukey’s post hoc test. C1 wild-type mice fed a standard diet, C2 ApcMin/+ fed a standard diet, E1 ApcMin/+ fed a standard diet supplemented with microencapsulated Bf and Lg, E2 ApcMin/+ fed a standard diet supplemented with microencapsulated Bf, Lg, and quercetin.